The influence of nucleoside transporters on anticancer effects of gemcitabine

The influence of nucleoside transporters on anticancer effects of gemcitabine - Nucleoside transporters and anticancer effects of gemcitabine

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004380

Enrollment

Registered

2010-10-14

Start date

2010-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Written informed consent

Exclusion criteria

Exclusion criteria: Inappropriate cases

Design outcomes

Primary

Measure	Time frame
overall survival	—

Secondary

Measure	Time frame
adverse events of gemcitabine	—

Countries

Japan

Contacts

Public ContactYoshiharu Suzuki

Tsukuba University Hospital Pharmacy Department

suzukiyo@hosp.tsukuba.ac.jp029-853-3843

Outcome results